Innate Pharma
IPHA
#8560
Rank
ยฃ94.81 M
Marketcap
ยฃ1.14
Share price
-11.66%
Change (1 day)
-42.60%
Change (1 year)

Revenue for Innate Pharma (IPHA)

Revenue in 2022: ยฃ41.98 Million

According to Innate Pharma 's latest financial reports the company's current revenue (TTM ) is ยฃ41.98 Million. In 2022 the company made a revenue of ยฃ41.98 Million an increase over the revenue in the year 2021 that were of ยฃ10.82 Million. The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.

Revenue history for Innate Pharma from 2005 to 2022

Annual revenue

Year Revenue Change
2022ยฃ41.98 M287.78%
2021ยฃ10.82 M-80.14%
2020ยฃ54.52 M-10.13%
2019ยฃ60.67 M-15.91%
2018ยฃ72.14 M133.44%
2017ยฃ30.9 M-33.72%
2016ยฃ46.63 M201.72%
2015ยฃ15.45 M1674.86%
2014ยฃ0.87 M-93.59%
2013ยฃ13.59 M25.45%
2012ยฃ10.83 M41.8%
2011ยฃ7.64 M68.46%
2010ยฃ4.53 M-48.02%
2009ยฃ8.72 M-38.81%
2008ยฃ14.26 M-13.41%
2007ยฃ16.47 M86.54%
2006ยฃ8.82 M286.35%
2005ยฃ2.28 M